Chronic insomnia affects an estimated 10–15% of adults and frequently occurs alongside costly chronic conditions. Yet despite evidence-based guidelines recommending Cognitive Behavioral Therapy for Insomnia (CBT-I) as first-line treatment, the way insomnia is treated today often looks very different.
Independent analysis of commercial claims data found that among patients with insomnia who received treatment, 96.9% were treated with prescription medications rather than CBT-I. For employers, this gap has implications beyond sleep, including employee health, healthcare utilization, productivity and quality of life.
Join Dr. Jason Ong and Employee Benefit News to explore why today’s approach to chronic insomnia is falling short, why CBT-I remains difficult to access, and how digital CBT-I and new models of care can help employers expand access to evidence-based treatment and improve sleep health across their workforce.
You’ll learn:
- How insomnia intersects with chronic conditions, mental health and healthcare utilization
- Why CBT-I is recommended as first-line treatment for chronic insomnia
- Why so many patients are treated with prescription sleep medications instead
- How digital CBT-I can help address longstanding barriers to treatment
- What employers and benefits leaders should consider when evaluating their approach to sleep health
